CTRI/2023/03/050796
Completed
Phase 4
â??Dermatological safety evaluation of test products by Primary Irritation Patch Test within 24 hours of apply on healthy human all skin types
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dabur India Limited
- Enrollment
- 24
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Voluntary men and women ratio of 1:1 between 18 and 65 years.
- •2\.Having healthy skin on test area as assessed by dermatological examination.
- •3\.For whom the investigator considers that the compliance will be correct.
- •4\.Subjects with normal, dry, oily and combination skin
- •5\.Subjects cooperating informed of the need and duration of the examination and ready to comply
- •with protocol procedures.
Exclusion Criteria
- •1\.Pregnant/nursing mothers.
- •2\.Scars, excessive terminal hair, or tattoo on the studied area.
- •3\.Dermatological infection/pathology on level of studied area.
- •4\.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material)
- •5\.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
To evaluate the safety of Primary Irritation Patch Test test product in healthy volunteersCTRI/2022/12/048219Vasu Health Care24
Completed
Not Applicable
Safety testing of cosmetic products by patch testCTRI/2021/12/038826Arbro pharmaceutical Pvt Ltd24
Completed
Not Applicable
Safety evaluation of cosmetic products by patch testCTRI/2022/02/040338Arbro pharmaceutical Pvt Ltd24
Completed
Not Applicable
Safety testing of cosmetic products by PIPT(Primary Irritation Patch Test)CTRI/2022/02/039947Arbro pharmaceutical Pvt Ltd24
Not yet recruiting
Not Applicable
To check dermatological safety of test products by 24 hours patch test on adult healthy human subjectsCTRI/2024/06/069652Kayura Effect LLP